This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Burger, P. C. Articles by Kleihues, P. Search for Related Content PubMed PubMed Citation Articles by Burger, P. C. Articles by Kleihues, P.

Selective Induction by N-Nitrosoethylurea of Oligodendrogliomas in Fetal Forebrain Transplants¹

Laboratory of Neuropathology, Institute of Pathology, University of Zürich, 8091 Zürich, Switzerland

Induction of neuroepithelial neoplasms by a single transplacental exposure to N-nitrosoethylurea (NEU) has been widely used as an experimental model for human brain tumors. NEU-induced gliomas are variably composed of neoplastic oligodendrocytes, astrocytes, and ependymal cells. It has remained controversial whether these neoplasms originate from differentiated glia or from pluripotent precursor cells of the subependymal matrix layer. We have taken a novel approach to define the histogenesis of these gliomas based on neural grafting techniques and the extraordinary difference in susceptibility between the fetal and adult brain to neoplastic transformation by alkylnitrosoureas. Pregnant rats received a single i.v. dose of NEU (50 mg/kg) on the 14th day of gestation. One day later, suspensions were prepared from the fetal forebrain and stereotactically injected into the caudoputamen of adult rats. These host animals received additional i.v. injections of NEU (50 mg/kg each) 8 days and 9 weeks posttransplantation. After a mean survival time of 316 days, all animals developed brain tumors within the neural graft. Histopathologically, these neoplasms were classified as oligodendrogliomas, ranging from early neoplastic foci to large, infiltrating malignant tumors. The selective induction of oligodendrogliomas indicates that neoplastic transformation in the nervous system can occur in a differentiated glial cell or in a precursor cell committed to oligodendrocytic differentiation, and that transformation of a pluripotential stem cell is not necessary. Omission of the first (prenatal) dose of NEU led to a much lower tumor incidence, whereas this dose in itself, i.e., without additional postgrafting exposure, did not produce brain tumors in any of the experimental animals. This differential effect of pre- and postgrafting exposure to NEU constitutes the first in vivo evidence of a multistep development of brain tumors.

¹ This work was supported by a grant from the Swiss National Science Foundation.

² Present address: Department of Pathology, Duke University Medical Center, Durham, NC 27710.

³ To whom requests for reprints should be addressed, at Institut für Pathologie, Universität Zürich, Universitätsspital, CH-8091 Zürich, Switzerland.

Received 11/16/87. Revised 1/29/88. Accepted 2/ 5/88.

This article has been cited by other articles:

				C. L. Nutt, M. Noble, A. F. Chambers, and J. G. Cairncross Differential Expression of Drug Resistance Genes and Chemosensitivity in Glial Cell Lineages Correlate with Differential Response of Oligodendrogliomas and Astrocytomas to Chemotherapy Cancer Res., September 1, 2000; 60(17): 4812 - 4818. [Abstract] [Full Text]

				B. C. Zook, S. J. Simmens, and R. V. Jones Evaluation of ENU-Induced Gliomas in Rats: Nomenclature, Immunochemistry, and Malignancy Toxicol Pathol, January 1, 2000; 28(1): 193 - 201. [Abstract] [PDF]